•  
  •  
  •  
  •  

2026-07-20 03:34:20

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Can Fin Homes Limited Delivers Strong Opening to FY27: Net Profit Rises 20% to ₹268 Crore Driven by Robust Disbursements
  • Punjab & Sind Bank Registers 23.05% Net Profit Surge in Q1 FY27 Powered by Robust Credit Growth and Improving Asset Quality
  • Bhansali Engineering Polymers Limited Marks Strong Start to FY27: Q1 Consolidated Net Profit Surges 42.9% to ₹65.60 Crore
  • Sangam India Ltd Reports Surge in Q1 FY27 Net Profit to ₹4,102 Lakhs
  • Rossari Biotech Limited Posts Steady Q1 FY27 Growth: Net Profit Rises to ₹350.95 Million

Keywords Selected:  APIFacility

Stock Report

  • Concord Biotech Ltd completes ANVISA Inspection conducted by the Brazilian Health Regulatory Agency at the Limbasi API Manufacturing Facility
  • Ipca Laboratories Ltd receives 3 observations from USFDA for API facility at Tarapur
  • Alembic Pharmaceuticals Ltd receives EIR from USFDA for facility at Panelav
  • Apitoria Pharma Pvt Ltd receives 5 observations from USFDA for API facility
  • Concord Biotech Limited completes EUGMP inspection at its API facility
  • Concord Biotech Ltd successfully completes Russian GMP insepction at its API facility
  • Concord Biotech Ltd announces successful completion EU GMP inspection at its API facility
  • Concord Biotech Limited receives EIR from USFDA for API facility at Dholka
  • Unichem Laboratories Ltd receives Form 483 from USFDA with 3 observations for Roha API facility
  • Zydus receives EIR for the API manufacturing facility at Dabhasa
  • USFDA Inspection at Concord Biotech Ltd's API facility at Dholka
  • Nectar Lifesciences Limited receives 7 observations from EDQM for API facility
  • Unichem Laboratories Ltd receives 4 observations from USFDA for Pithampur API facility
  • Senores Pharmaceuticals begins operations at greenfield API facility
  • Bajaj Healthcare Ltd's API facility receives approval from TGA, Australia
  • Apitoria Pharma Pvt Ltd gets Form 483 with 10 observations from US FDA
  • Dr. Reddy's Laboratories Limited gets Form 483 from USFDA with 4 observations for API facility
  • Shivalik Rasayan Ltd's API facility gets 7 observations from USFDA
  • Concord Biotech Limited receives EUGMP certificate for Dholka facility
  • Zydus receives Post Application Action Letter for the USFDA cGMP nd Pre-Approval Inspection at the Ahmedabad API facility
  • EDQM conducts GMP inspection of SMS Pharmaceuticals Ltd's API facility
  • Bajaj Healthcare Ltd receives EIR from USFDA for API manufacturing facility in Savli
  • Shilpa Pharma Lifesciences Ltd, Unit II, Raichur, Karnataka has cleared PMDA Japan, GMP inspection
  • Smruthi Organics Ltd's API site completes inspection by South Korean regulator

Latest Post

  • Can Fin Homes Limited Delivers Strong Opening to FY27: Net Profit Rises 20% to ₹268 Crore Driven by Robust Disbursements
  • Punjab & Sind Bank Registers 23.05% Net Profit Surge in Q1 FY27 Powered by Robust Credit Growth and Improving Asset Quality
  • Bhansali Engineering Polymers Limited Marks Strong Start to FY27: Q1 Consolidated Net Profit Surges 42.9% to ₹65.60 Crore
  • Sangam India Ltd Reports Surge in Q1 FY27 Net Profit to ₹4,102 Lakhs
  • Rossari Biotech Limited Posts Steady Q1 FY27 Growth: Net Profit Rises to ₹350.95 Million


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025